Sarum Biosciences Limited

POWER SEARCH PRICING

SOLUTIONS

sarum biosciences limited Company Information

Live

MatureMicroDeclining

Company Number

04879899

Next Accounts

Sep 2025

Industry

Research and experimental development on biotechnology

Directors

David West

Thomas Hone

Shareholders

david mackay west

thomas nathaniel hone

View All

Group Structure

View All

Contact

Registered Address

29 attwood road, salisbury, SP1 3PR

Website

https://sarumbiosciences.co.uk

sarum biosciences limited Estimated Valuation

£91.6k

Pomanda estimates the enterprise value of SARUM BIOSCIENCES LIMITED at £91.6k based on Net Assets of £48.5k and 1.89x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Sarum Biosciences Limited is a live company located in salisbury, SP1 3PR with a Companies House number of 04879899. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in August 2003, it's largest shareholder is david mackay west with a 40% stake. Sarum Biosciences Limited is a mature, micro sized company, Pomanda has estimated its turnover at £62.5k with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Sarum Biosciences Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs

Health Rating1.5out of 5

1 Strong

2 Regular

7 Weak

Size

annual sales of £62.5k, make it smaller than the average company (£4.4m)

Growth

3 year (CAGR) sales growth of -14%, show it is growing at a slower rate (13.8%)

EXPORT

Sarum Biosciences Limited's latest turnover from December 2023 is estimated at £62.5 thousand and the company has net assets of £48.5 thousand. According to their latest financial statements, Sarum Biosciences Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Turnover	62,473	79,836	90,789	99,433	82,666	107,346	48,906	112,049	50,664	39,353	31,896	78,044	123,754	74,306	0
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	45,615	57,331	65,947	69,462	57,731	75,082	34,302	78,056	35,311	27,513	22,806	58,886	93,817	54,957	0
Gross Profit	16,858	22,505	24,841	29,971	24,935	32,263	14,604	33,993	15,353	11,840	9,090	19,158	29,937	19,349	0
Admin Expenses	34,930	-101,793	30,282	35,486	-824,348	39,152	21,447	67,254	18,765	24,128	41,613	81,799	117,961	51,433	433,626
Operating Profit	-18,072	124,298	-5,441	-5,515	849,283	-6,889	-6,843	-33,261	-3,412	-12,288	-32,523	-62,641	-88,024	-32,084	-433,626
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	0	0	0	0	6	16	25	13	23	47	89	103	94	57	7
Pre-Tax Profit	-18,072	124,298	-5,441	-5,515	849,289	-6,873	-6,818	-33,248	-3,389	-12,241	-32,434	-62,538	-87,930	-32,027	-433,619
Tax	0	-23,617	0	0	-161,365	0	0	0	0	0	0	0	0	0	0
Profit After Tax	-18,072	100,681	-5,441	-5,515	687,924	-6,873	-6,818	-33,248	-3,389	-12,241	-32,434	-62,538	-87,930	-32,027	-433,619
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-18,072	100,681	-5,441	-5,515	687,924	-6,873	-6,818	-33,248	-3,389	-12,241	-32,434	-62,538	-87,930	-32,027	-433,619
Employee Costs	171,207	157,514	156,244	140,785	68,289	67,699	60,703	57,602	54,775	56,317	52,549	52,097	53,305	51,809	0
Number Of Employees	2	2	2	2	1	1	1	1	1	1	1	1	1	1	0
EBITDA*	-18,072	124,298	-5,441	-5,515	849,283	-1,089	-1,043	-27,461	2,388	-6,488	-32,523	-57,007	-45,069	-31,276	-432,830

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Tangible Assets	38,610	43,751	48,892	54,033	59,174	48	707	1,366	2,025	2,684	3,343	4,095	4,634	5,177	5,985
Intangible Assets	0	0	0	0	0	64,315	69,456	74,597	79,738	84,879	89,173	90,396	67,118	50,944	0
Investments & Other	0	0	0	0	0	19,790	19,909	19,784	19,665	19,548	19,308	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	38,610	43,751	48,892	54,033	59,174	84,153	90,072	95,747	101,428	107,111	111,824	94,491	71,752	56,121	5,985
Stock & work in progress	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Debtors	10,263	23,222	23,944	23,944	24,004	0	4,200	0	6,426	137	758	20,141	38,674	21,975	17,615
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	0	0	0	0	0	3,500	0	0	0	0	0	0	0	0	0
Cash	0	0	0	0	0	1,555	2,658	7,345	2,795	6,535	12,394	23,394	17,801	19,892	2,898
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	10,263	23,222	23,944	23,944	24,004	5,055	6,858	7,345	9,221	6,672	13,152	43,535	56,475	41,867	20,513
total assets	48,873	66,973	72,836	77,977	83,178	89,208	96,930	103,092	110,649	113,783	124,976	138,026	128,227	97,988	26,498
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	413	441	106,985	106,685	106,371	106,285	106,384	106,284	105,619	105,864	104,816	129,982	119,233	26,164	14,272
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	0	0	0	0	0	332	1,082	526	500	0	0	0	0	0	0
total current liabilities	413	441	106,985	106,685	106,371	106,617	107,466	106,810	106,119	105,864	104,816	129,982	119,233	26,164	14,272
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total liabilities	413	441	106,985	106,685	106,371	106,617	107,466	106,810	106,119	105,864	104,816	129,982	119,233	26,164	14,272
net assets	48,460	66,532	-34,149	-28,708	-23,193	-17,409	-10,536	-3,718	4,530	7,919	20,160	8,044	8,994	71,824	12,226
total shareholders funds	48,460	66,532	-34,149	-28,708	-23,193	-17,409	-10,536	-3,718	4,530	7,919	20,160	8,044	8,994	71,824	12,226

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Operating Activities
Operating Profit	-18,072	124,298	-5,441	-5,515	849,283	-6,889	-6,843	-33,261	-3,412	-12,288	-32,523	-62,641	-88,024	-32,084	-433,626
Depreciation	0	0	0	0	0	659	659	659	659	659	0	729	729	808	796
Amortisation	0	0	0	0	0	5,141	5,141	5,141	5,141	5,141	0	4,905	42,226	0	0
Tax	0	-23,617	0	0	-161,365	0	0	0	0	0	0	0	0	0	0
Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors	-12,959	-722	0	-60	20,504	-700	4,200	-6,426	6,289	-621	-19,383	-18,533	16,699	4,360	17,615
Creditors	-28	-106,544	300	314	86	-99	100	665	-245	1,048	-25,166	10,749	93,069	11,892	14,272
Accruals and Deferred Income	0	0	0	0	-332	-750	556	26	500	0	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-5,141	-5,141	-5,141	-5,141	667,168	-1,238	-4,587	-20,344	-3,646	-4,819	-38,306	-27,725	31,301	-23,744	-436,173
Investing Activities
capital expenditure	5,141	5,141	5,141	5,141	5,189	0	0	0	0	-847	1,975	-28,373	-58,586	-50,944	-6,781
Change in Investments	0	0	0	0	-19,790	-119	125	119	117	240	19,308	0	0	0	0
cash flow from investments	5,141	5,141	5,141	5,141	24,979	119	-125	-119	-117	-1,087	-17,333	-28,373	-58,586	-50,944	-6,781
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	0	0	-693,708	0	0	25,000	0	0	44,550	61,588	25,100	91,625	445,845
interest	0	0	0	0	6	16	25	13	23	47	89	103	94	57	7
cash flow from financing	0	0	0	0	-693,702	16	25	25,013	23	47	44,639	61,691	25,194	91,682	445,852
cash and cash equivalents
cash	0	0	0	0	-1,555	-1,103	-4,687	4,550	-3,740	-5,859	-11,000	5,593	-2,091	16,994	2,898
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	0	0	0	0	-1,555	-1,103	-4,687	4,550	-3,740	-5,859	-11,000	5,593	-2,091	16,994	2,898

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for sarum biosciences limited. Get real-time insights into sarum biosciences limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for sarum biosciences limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in SP1 area or any other competitors across 12 key performance metrics.

SARUM BIOSCIENCES LIMITED group structure

Sarum Biosciences Limited has no subsidiary companies.

Ultimate parent company

SARUM BIOSCIENCES LIMITED

04879899

SARUM BIOSCIENCES LIMITED Shareholders

david mackay west	40.04%
thomas nathaniel hone	11.16%
anthony atkinson	7.41%
angus john stormonth darling	4.55%
robert s. mason	4.38%
university of leeds	3.55%
fusion ip plc	2.33%
patrick robertson gammell	2.09%
francis g.s lukas	1.7%
charles ingleby	1.64%

Sarum Biosciences Limited currently has 2 directors. The longest serving directors include Dr David West (Aug 2003) and Mr Thomas Hone (Mar 2005).

officer	country	age	start	end	role
Dr David West		54 years	Aug 2003	-	Director
Mr Thomas Hone		69 years	Mar 2005	-	Director

P&L

December 2023

turnover

62.5k

-22%

operating profit

-18.1k

gross margin

27%

-4.27%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

48.5k

-0.27%

total assets

48.9k

-0.27%

cash

net assets

Total assets minus all liabilities

Similar Companies

atopix therapeutics limited

2.5

respiratory clinical trials limited

biopharm enterprises limited

2.5

the blond mcindoe research foundation

globalacorn ltd

2.5

company number

04879899

Type

Private limited with Share Capital

industry

72110 - Research and experimental development on biotechnology

incorporation date

August 2003

ultimate parent company

None

previous names

N/A

address

29 attwood road, salisbury, SP1 3PR

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to sarum biosciences limited.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for SARUM BIOSCIENCES LIMITED. This can take several minutes, an email will notify you when this has completed.

sarum biosciences limited Company Information

sarum biosciences limited Estimated Valuation

sarum biosciences limited Estimated Valuation

sarum biosciences limited Estimated Valuation

Sarum Biosciences Limited Overview

Sarum Biosciences Limited Health Check

SARUM BIOSCIENCES LIMITED financials

sarum biosciences limited Credit Report and Business Information

Sarum Biosciences Limited Competitor Analysis

sarum biosciences limited Ownership

sarum biosciences limited directors

sarum biosciences limited company details

sarum biosciences limited Charges & Mortgages

sarum biosciences limited Capital Raised & Share Issues BETA

sarum biosciences limited Companies House Filings - See Documents